NCT04577326 2025-07-25
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
Clinical Trials
3 trialsNCT05268172 2024-05-16
IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites
Affiliated Hospital of Jiangnan University
Phase 1 Recruiting
NCT03525782 2018-05-16
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
The First Affiliated Hospital of Guangdong Pharmaceutical University
Phase 1/2 Unknown